Showing results (1601-1610 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|September 18, 2023
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myelomaKenta Yamaoka, Kei Irie, Nobuhiro Hiramoto, et al.Investigational New Drugs|January 26, 2019
The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse modelNarine Ghazaryan, Naira Movsisyan, Joana Catarina Macedo, et al.Investigational New Drugs|January 29, 2019
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric CancerGiandomenico Roviello, Roberto Petrioli, Pietro Rosellini, et al.Investigational New Drugs|February 2, 2019
Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivoJuan Ma, Tengfei Shang, Pan Ma, et al.Investigational New Drugs|February 2, 2019
Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell linesViviane A O Silva, Marcela N Rosa, Olga Martinho, et al.Investigational New Drugs|January 5, 2019
MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancerShaohua Ge, Haiyang Zhang, Ting Deng, et al.Investigational New Drugs|January 7, 2019
Biodistribution, pharmacokinetics and radioimmunotherapy of 188Re-cetuximab in NCI-H292 human lung tumor-bearing nude miceYa-Jen Chang, Chung-Li Ho, Kai-Hung Cheng, et al.Investigational New Drugs|February 9, 2019
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancerAnsheng Wang, Chengling Zhao, Yuan Gao, et al.Investigational New Drugs|September 27, 2020
The bromodomain and extra-terminal domain inhibitor JQ1 synergistically sensitizes human colorectal cancer cells to topoisomerase I inhibitors through repression of Mre11-mediated DNA repair pathwayLinping Lei, Xuqin Xie, Long He, et al.Investigational New Drugs|January 1, 1987
Overview of preclinical and clinical studies of interferon alfa-2b in combination with cytotoxic drugsC E WelanderPageof 372